The nocebo effect challenges the non-medical infliximab switch in practice.
Eur J Clin Pharmacol
; 74(5): 655-661, 2018 May.
Article
in En
| MEDLINE
| ID: mdl-29368188
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arthritis, Rheumatoid
/
Spondylitis, Ankylosing
/
Gastrointestinal Agents
/
Inflammatory Bowel Diseases
/
Arthritis, Psoriatic
/
Antirheumatic Agents
/
Biosimilar Pharmaceuticals
/
Infliximab
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Eur J Clin Pharmacol
Year:
2018
Document type:
Article
Affiliation country: